DDW: Anti-MAdCAM antibody hits endpoints in treatment-refractory UC

WASHINGTON – The anti-MAdCAM candidate, PF-00547659, induced responses in up to 54% of patients with moderately to severely active ulcerative colitis failing at least one prior therapy.

At the...